Literature DB >> 22617348

Variants in the 3'UTR of SNCA do not affect miRNA-433 binding and alpha-synuclein expression.

Ina Schmitt1, Ullrich Wüllner, Jan Pierre van Rooyen, Hassan Khazneh, Julian Becker, Alexander Volk, Christian Kubisch, Tim Becker, Vladimir S Kostic, Christine Klein, Alfredo Ramirez.   

Abstract

Alpha-synuclein (SNCA) is a major risk gene for Parkinson's disease (PD) and increased SNCA gene dosage results in a parkinsonian syndrome in affected families. Regulatory regions relevant for SNCA expression include the 3' untranslated region (UTR), which among other regulatory elements contains several micro-RNA-binding sites. Interestingly, variants located in the 3' region of SNCA have been associated with PD in two genome-wide association studies. To test whether private mutations in this region contribute to PD, we sequenced the 3'UTR of SNCA in 1285 PD patients and 1120 age/sex-matched healthy controls. We found two rare variants, the one corresponding to the single nucleotide polymorphism rs145304567 and the novel variant c.*1004_1008delTTTTT. Although rs145304567 affects the putative-binding site of microRNA (miRNA) -433, the allele distribution was similar in PD patients and controls, and the expression of SNCA mRNA was not related to the genotype. Furthermore, a regulatory effect of miRNA-433 on SNCA expression levels was not detected.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22617348      PMCID: PMC3499742          DOI: 10.1038/ejhg.2012.84

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  19 in total

1.  A search for SNCA 3' UTR variants identified SNP rs356165 as a determinant of disease risk and onset age in Parkinson's disease.

Authors:  Lucía F Cardo; Eliecer Coto; Lorena de Mena; René Ribacoba; Oswaldo Lorenzo-Betancor; Pau Pastor; Lluis Samaranch; Ignacio F Mata; Marta Díaz; Germán Moris; Manuel Menéndez; Ana I Corao; Victoria Alvarez
Journal:  J Mol Neurosci       Date:  2011-11-11       Impact factor: 3.444

2.  Staging of brain pathology related to sporadic Parkinson's disease.

Authors:  Heiko Braak; Kelly Del Tredici; Udo Rüb; Rob A I de Vos; Ernst N H Jansen Steur; Eva Braak
Journal:  Neurobiol Aging       Date:  2003 Mar-Apr       Impact factor: 4.673

3.  Alpha-synuclein in Lewy bodies.

Authors:  M G Spillantini; M L Schmidt; V M Lee; J Q Trojanowski; R Jakes; M Goedert
Journal:  Nature       Date:  1997-08-28       Impact factor: 49.962

4.  Multiple candidate gene analysis identifies alpha-synuclein as a susceptibility gene for sporadic Parkinson's disease.

Authors:  Ikuko Mizuta; Wataru Satake; Yuko Nakabayashi; Chiyomi Ito; Satoko Suzuki; Yoshio Momose; Yoshitaka Nagai; Akira Oka; Hidetoshi Inoko; Jiro Fukae; Yuko Saito; Motoji Sawabe; Shigeo Murayama; Mitsutoshi Yamamoto; Nobutaka Hattori; Miho Murata; Tatsushi Toda
Journal:  Hum Mol Genet       Date:  2006-02-24       Impact factor: 6.150

5.  alpha-Synuclein and Parkinson disease susceptibility.

Authors:  S Winkler; J Hagenah; S Lincoln; M Heckman; K Haugarvoll; K Lohmann-Hedrich; V Kostic; M Farrer; C Klein
Journal:  Neurology       Date:  2007-09-13       Impact factor: 9.910

6.  Genetic variability in the SNCA gene influences alpha-synuclein levels in the blood and brain.

Authors:  Julia Fuchs; Ales Tichopad; Yulia Golub; Marita Munz; Katherine J Schweitzer; Björn Wolf; Daniela Berg; Jakob C Mueller; Thomas Gasser
Journal:  FASEB J       Date:  2007-12-27       Impact factor: 5.191

7.  Parkinson's Disease Society Brain Bank, London: overview and research.

Authors:  S E Daniel; A J Lees
Journal:  J Neural Transm Suppl       Date:  1993

8.  Vascular development in the retina and inner ear: control by Norrin and Frizzled-4, a high-affinity ligand-receptor pair.

Authors:  Qiang Xu; Yanshu Wang; Alain Dabdoub; Philip M Smallwood; John Williams; Chad Woods; Matthew W Kelley; Li Jiang; William Tasman; Kang Zhang; Jeremy Nathans
Journal:  Cell       Date:  2004-03-19       Impact factor: 41.582

9.  Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein.

Authors:  Gaofeng Wang; Joelle M van der Walt; Gregory Mayhew; Yi-Ju Li; Stephan Züchner; William K Scott; Eden R Martin; Jeffery M Vance
Journal:  Am J Hum Genet       Date:  2008-01-31       Impact factor: 11.025

10.  Elevated alpha-synuclein mRNA levels in individual UV-laser-microdissected dopaminergic substantia nigra neurons in idiopathic Parkinson's disease.

Authors:  Jan Gründemann; Falk Schlaudraff; Olga Haeckel; Birgit Liss
Journal:  Nucleic Acids Res       Date:  2008-03-10       Impact factor: 16.971

View more
  10 in total

1.  SNCA 3'UTR genetic variants in patients with Parkinson's disease and REM sleep behavior disorder.

Authors:  M Toffoli; E Dreussi; E Cecchin; M Valente; N Sanvilli; M Montico; S Gagno; M Garziera; M Polano; M Savarese; G Calandra-Buonaura; F Placidi; M Terzaghi; G Toffoli; G L Gigli
Journal:  Neurol Sci       Date:  2017-04-13       Impact factor: 3.307

Review 2.  MicroRNAs in Parkinson's disease.

Authors:  Abhishek Singh; Dwaipayan Sen
Journal:  Exp Brain Res       Date:  2017-05-19       Impact factor: 1.972

3.  Genetic analysis of α-synuclein 3' untranslated region and its corresponding microRNAs in relation to Parkinson's disease compared to dementia with Lewy bodies.

Authors:  Lidia Tagliafierro; Omolara-Chinue Glenn; Madison E Zamora; Thomas G Beach; Randy L Woltjer; Michael W Lutz; Ornit Chiba-Falek
Journal:  Alzheimers Dement       Date:  2017-04-18       Impact factor: 21.566

Review 4.  Role of microRNAs in the Regulation of α-Synuclein Expression: A Systematic Review.

Authors:  Ariadna Recasens; Celine Perier; Carolyn M Sue
Journal:  Front Mol Neurosci       Date:  2016-11-21       Impact factor: 5.639

Review 5.  Genetic Variants in SNCA and the Risk of Sporadic Parkinson's Disease and Clinical Outcomes: A Review.

Authors:  Clarissa Loureiro das Chagas Campêlo; Regina Helena Silva
Journal:  Parkinsons Dis       Date:  2017-07-11

6.  Using KASP technique to screen LRRK2 G2019S mutation in a large Tunisian cohort.

Authors:  Zied Landoulsi; Sawssan Benromdhan; Mouna Ben Djebara; Mariem Damak; Hamza Dallali; Rym Kefi; Sonia Abdelhak; Amina Gargouri-Berrechid; Chokri Mhiri; Riadh Gouider
Journal:  BMC Med Genet       Date:  2017-07-06       Impact factor: 2.103

7.  Alpha-synuclein mRNA isoform formation and translation affected by polymorphism in the human SNCA 3'UTR.

Authors:  Elizabeth S Barrie; Sung-Ha Lee; John T Frater; Maria Kataki; Douglas W Scharre; Wolfgang Sadee
Journal:  Mol Genet Genomic Med       Date:  2018-05-06       Impact factor: 2.183

8.  miRNAs and their putative roles in the development and progression of Parkinson's disease.

Authors:  Garry Wong; Richard Nass
Journal:  Front Genet       Date:  2013-01-09       Impact factor: 4.599

Review 9.  Neuronal dark matter: the emerging role of microRNAs in neurodegeneration.

Authors:  Emily F Goodall; Paul R Heath; Oliver Bandmann; Janine Kirby; Pamela J Shaw
Journal:  Front Cell Neurosci       Date:  2013-10-10       Impact factor: 5.505

10.  SNCA 3' UTR Genetic Variants in Patients with Parkinson's Disease.

Authors:  Antonela Blažeković; Kristina Gotovac Jerčić; Fran Borovečki
Journal:  Biomolecules       Date:  2021-11-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.